A detailed history of Barings LLC transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Barings LLC holds 67,998 shares of BGNE stock, worth $12.1 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
67,998
Previous 51,763 31.36%
Holding current value
$12.1 Million
Previous $7.39 Million 106.72%
% of portfolio
0.38%
Previous 0.19%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$143.93 - $224.51 $2.34 Million - $3.64 Million
16,235 Added 31.36%
67,998 $15.3 Million
Q2 2024

Aug 08, 2024

BUY
$129.52 - $174.32 $2.68 Million - $3.6 Million
20,663 Added 66.44%
51,763 $7.39 Million
Q1 2024

May 08, 2024

SELL
$141.8 - $181.47 $4.15 Million - $5.31 Million
-29,279 Reduced 48.49%
31,100 $4.86 Million
Q4 2023

Feb 08, 2024

BUY
$158.67 - $201.58 $9.58 Million - $12.2 Million
60,379 New
60,379 $10.9 Million
Q4 2021

Feb 09, 2022

SELL
$248.56 - $389.34 $229,669 - $359,750
-924 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$249.6 - $403.14 $230,630 - $372,501
924 New
924 $335,000
Q1 2020

May 15, 2020

SELL
$121.84 - $173.19 $2.17 Million - $3.09 Million
-17,842 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$115.78 - $208.34 $100,960 - $181,672
-872 Reduced 4.66%
17,842 $2.96 Million
Q3 2019

Nov 13, 2019

SELL
$120.61 - $148.29 $5.4 Million - $6.64 Million
-44,767 Reduced 70.52%
18,714 $2.29 Million
Q2 2019

Aug 12, 2019

SELL
$113.99 - $146.86 $34,766 - $44,792
-305 Reduced 0.48%
63,481 $7.87 Million
Q1 2019

May 08, 2019

SELL
$122.82 - $151.83 $8.15 Million - $10.1 Million
-66,385 Reduced 51.0%
63,786 $8.42 Million
Q4 2018

Feb 07, 2019

BUY
$107.01 - $175.15 $3.42 Million - $5.59 Million
31,915 Added 32.48%
130,171 $18.3 Million
Q3 2018

Oct 26, 2018

SELL
$152.62 - $189.66 $8.34 Million - $10.4 Million
-54,648 Reduced 35.74%
98,256 $16.9 Million
Q2 2018

Aug 03, 2018

BUY
$152.5 - $216.77 $6.08 Million - $8.64 Million
39,848 Added 35.25%
152,904 $23.5 Million
Q1 2018

May 04, 2018

BUY
$97.41 - $177.22 $11 Million - $20 Million
113,056 New
113,056 $19 Million

Others Institutions Holding BGNE

About BeiGene, Ltd.


  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $18.4B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Barings LLC Portfolio

Follow Barings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Barings LLC with notifications on news.